The 7th Annual Glaucoma 360 New Horizons Forum took place at the Palace Hotel in San Francisco on February 9, 2018.
New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment. Launched in 2012 by the Glaucoma Research Foundation, this catalyst meeting is designed to speed the translation of new ideas and technologies into clinical practice.
Adrienne Graves, PhD, Glaucoma 360 Co-Founder, introduced the 7th Annual New Horizons Forum.
Iqbal Ike K. Ahmed, MD, FRCSC delivered the Opening Keynote Address.
Andrew D. Huberman, PhD moderated the session on New Horizons in Virtual Reality.
Felipe Medeiros, MD, PhD co-moderated the Virtual Reality session.
L-R: Richard A. Lewis, MD, Andrew G. Iwach, MD, Adrienne L. Graves, PhD, and Joel S. Schuman, MD, FACS
L-R: Drs. Malvina Eydelman, Kuldev Singh, and Wiley A. Chambers enjoy participating in the session FDA: Getting to New Horizons.
Attendees at the 7th annual New Horizons Forum
Exhibits and networking at New Horizons
During breaks, exhibits are open for exploration and learning.
Exhibits and networking in the Sunset Court at New Horizons Forum, the Palace Hotel, San Francisco.
Networking at the closing reception for New Horizons
Keynote speaker Ike Ahmed, MD is interviewed during Glaucoma 360 New Horizons Forum.
Save the date for the 8th Annual Glaucoma 360 New Horizons Forum: February 1, 2019.
There is great interest among glaucoma patients, scientists and doctors alike, in discovering regenerative therapies for the optic nerve and translating them from the laboratory to the clinic — and stem cell therapy is one of several promising approaches being studied.